Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Diabetic Retinopathy

• Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy
• A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
• Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
• A Study of PER-001 in Participants With Diabetic Retinopathy
• Cool vs Room-temperature Artificial Tears
• Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy
• Safety and Efficacy of Faricimab in Patients With NPDR
• Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients
• Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
• Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
• Effect of Corona Virus on Intravitreal Injections
• Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy
• OTT166 in Diabetic Retinopathy (DR)
• Phase 2 Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Non-proliferative Diabetic Retinopathy
• Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy
• Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
• Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy
• Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
• A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy
• A Study on the Treatment Strategy of NVG Secondary to PDR
• Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
• Treating Early Stage Diabetic Retinopathy
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR)
• A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.
• A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)
• Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy
• Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema
• A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment
• Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume
• Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR
• A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR)
• Non-proliferative Diabetic Retinopathy Treated With Runcaciguat
• Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial
• Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye
• Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy
• Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
• Fenofibrate for Prevention of DR Worsening
• Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO
• RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)
• Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.
• Sleep, Diabetic Retinopathy and Melatonin
• A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
• Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
• INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study
• A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Com
• Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema
• Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema
• HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia
• DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery
• Using Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic Retinopathy
• A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
• Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD
• MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
• Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
• Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients
• Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
• The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (
• A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®
• PRP vs PRP+IVC for Severe nPDR
• Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
• Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy
• A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)
• Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema
• Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
• A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)
• Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT)
• A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)
• Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
• Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
• Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)
• Lowering Events in Non-proliferative Retinopathy in Scotland
• Intravitreal Conbercept After Vitrectomy
• PROMINENT-Eye Ancillary Study (Protocol AD)
• A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy
• A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.
• The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)
• Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
• A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)
• The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
• Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
• Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
• Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema
• Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy
• CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
• Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
• Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy
• Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy
• Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
• Ocular Discomfort Assessment After Intravitreal Injections
• Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
• A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR
• Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
• The Effect of Dopamine on Diabetic Retinopathy
• PRP vs Bevacizumab for PDR Treatment
• A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR
• Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma
• Anti-VEGF Treatment for Prevention of PDR/DME
• Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN
• Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy
• Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens
• Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
• Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
• Study of Topical Ocular PAN-90806 in PDR
• Photobiomodulation for the Treatment of Diabetic Macular Edema
• 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial
• A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
• Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)
• Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
• Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema
• Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)
• Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients
• 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
• PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs
• Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema
• Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
• Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.
• Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
• Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
• Analysis of Aqueous and Vitreous Humor
• Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy
• Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
• PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy
• Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
• Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy
• Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With Hig
• Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes
• Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
• Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy
• An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
• Nepafenac Once Daily for Macular Edema - Study 2
• Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X
• Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
• Nepafenac Once Daily for Macular Edema - Study 1
• Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage
• Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
• Aflibercept Injection for Proliferative Diabetic Retinopathy
• Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• Squalamine for the Treatment in Proliferative Diabetic Retinopathy
• Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
• Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
• Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
• Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
• Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
• Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
• The Role of Prostaglandins in the Progression of Diabetic Retinopathy
• Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
• Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
• A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
• A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)
• Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
• Propranolol for Diabetic Retinopathy
• A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
• Effect of the Adjunctive IVB Before PRP
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
• Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema
• A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy
• Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)
• Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
• Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
• PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
• Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy
• Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy
• The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
• Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
• Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study
• Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• Diabetic Retinopathy Sulodexide Study
• Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
• Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferativ
• Avastin for PDR (Proliferative Diabetic Retinopathy)
• Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
• Topical Application of Latanoprost in Diabetic Retinopathy
• Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation
• Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
• Ranibizumab for Diabetic Traction Retinal Detachment
• Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema
• Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
• Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
• Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery
• Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease
• Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
• Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)
• Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)
• Macular Edema Incidence/Severity Reduction With Nevanac
• Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
• Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
• A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
• Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy
• A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy
• Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
• Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab
• Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
• The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy
• The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
• Combined Triple Therapy in Diabetic Retinopathy (DRP)
• Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab
• A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
• Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab
• Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy
• Sirolimus to Treat Diabetic Macular Edema
• Intravitreal Bevacizumab for Diabetic Macular Edema
• Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema
• Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)
• Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)
• Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation
• Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation
• Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
• Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
• Bevacizumab and Long Acting Gas in Diabetic Vitrectomy
• Pharmacological Intervention in Diabetic Retinopathy
• Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging
• Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
• Intravitreal Bevacizumab for Diabetic Retinopathy
• Preoperative Bevacizumab for Vitreous Hemorrhage
• Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
• Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
• Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)
• Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation
• Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
• Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
• Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
• Treatment of Refractory Diabetic Macular Edema With Infliximab
• Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
• Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
• A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)
• Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
• Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
• Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
• A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers
• Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
• Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema
• Retinal Blood Flow and Microthrombi in Type 1 Diabetes
• Intravitreal Bevacizumab for Retinal Disorders
• Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
• Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
• Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy
• The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes
• A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
• Treatment for Completers of the Study B7A-MC-MBCM
• Diabetic Retinopathy Candesartan Trials
• DIabetic Retinopathy Candesartan Trials.
• DIabetic Retinopathy Candesartan Trials
• Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
• Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
• Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema
• PST/Laser v. Laser Alone for CSME
• Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
• Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
• Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
• Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients
• Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
• Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
• Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
• Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
• Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders
• Reduction in the Occurrence of Center-Involved Diabetic Macular Edema
• Research Study in Patients With Persistent Macular Edema
• Sorbinil Retinopathy Trial (SRT)
• Early Treatment Diabetic Retinopathy Study (ETDRS)